====== Comparative binding energy analysis (COMBINE) ======

First description of the COMBINE analysis method : {{pubmed>long:7629807}}


----


  - {{pubmed>long:23532250}}
  - {{pubmed>long:23450741}}
  - {{pubmed>long:22925713}}
  - {{pubmed>long:22762501}}
  - {{pubmed>long:22431398}}
  - {{pubmed>long:20205431}}
  - {{pubmed>long:19768680}}
  - {{pubmed>long:19705486}}
  - {{pubmed>long:19492438}}
  - {{pubmed>long:19251817}}
  - {{pubmed>long:18540590}}
  - Masamoto Arakawaa, Kiyoshi Hasegawab, Kimito Funatsu: Tailored scoring function of Trypsin–benzamidine complex using COMBINE descriptors and support vector regression. Chemometrics and Intelligent Laboratory Systems, Volume 92, Issue 2, 15 July 2008, Pages 145-151.
  - {{pubmed>long:17329110}}
  - {{pubmed>long:17295314}}
  - {{pubmed>long:17627522}}
  - Martin B. Peters, Kenneth M. Merz Jr.: Semiempirical Comparative Binding Energy Analysis (SE-COMBINE) of a Series of Trypsin Inhibitors. J. Chem. Theory Comput., 2006, 2 (2), pp 383–399.
  - {{pubmed>long:16454757}}
  - {{pubmed>long:17027266}}
  - Marta Murcia, Antonio Morreale, Angel R. Ortiz: Comparative Binding Energy Analysis Considering Multiple Receptors: A Step toward 3D-QSAR Models for Multiple Targets. J. Med. Chem., 2006, 49 (21), pp 6241–6253. [[http://pubs.acs.org/doi/abs/10.1021/jm060350h|link]]
  - {{pubmed>long:15736949}}
  - {{pubmed>long:15345541}}
  - Rebecca C. Wade, Stefan Henrich, Ting Wang: Using 3D protein structures to derive 3D-QSARs. Drug Discovery Today: Technologies, Volume 1, Issue 3, December 2004, Pages 241-246.
  - {{pubmed>long:15533451}}
  - {{pubmed>long:14995186}}
  - {{pubmed>long:14761183}}
  - {{pubmed>long:15317459}}
  - {{pubmed>long:15028256}}
  - {{pubmed>long:15481986}}
  - {{pubmed>long:15142553}}
  - Jiri Damborsky, Jan Kmunicek, Tomas Jedlicka,Santos Luengo, Federico Gago, Angel R. Ortiz and Rebecca C. Wade: Rational Re-design of Haloalkane Dehalogenases Guided by Comparative Binding Energy Analysis. In "Enzyme functionality: Design, Engineering and Screening", Ed. A. Svendsen, Marcel Dekker, New York, ISBN: 0-8247-4709-7 (2004) pp79-96.
  - {{pubmed>long:14635723}}
  - {{pubmed>long:12383008}}
  - {{pubmed>long:12463642}}
  - {{pubmed>long:11300878}}
  - Ting Wang, Rebecca C. Wade: COMBINE 3D-QSAR Analysis of Influenza Neuraminidase Inhibitors. In: "Rational Approaches to Drug Design: 13th European Symposium on Quantitative Structure-Activity Relationships", Eds. Holtje, H-D., Sippl,W. (2001), Prous Science S.A., Barcelona, pp78-82.
  - Rebecca C. Wade: Derivation of QSARs using 3D structural models of protein-ligand complexes. In: "Rational Approaches to Drug Design: 13th European Symposium on Quantitative Structure-Activity Relationships", Eds. Holtje, H-D., Sippl,W. (2001), Prous Science S.A., Barcelona, pp23-28.
  - Sanja Tomica, Rebecca C. Wade: COMBINE Analysis of Nuclear Receptor-DNA Binding Specificity: Comparison of Two Sets of Data. CROATICA CHEMICA ACTA CCACAA 74 (2) 295-314 (2001), ISSN-0011-1643 CCA-2733 Original Scientific Paper.
  - {{pubmed>long:11467952}}
  - {{pubmed>long:11812259}}
  - Sanja Tomic,Lennart Nilsson, Rebecca C. Wade: Nuclear Receptor−DNA Binding Specificity:  A COMBINE and Free−Wilson QSAR Analysis. J. Med. Chem., 2000, 43 (9), pp 1780–1792.
  - M. Pastor, F. Gago, G. Cruciani: Comparative binding energy (COMBINE) analysis on a series of glycogen phosphorylase inhibitors: comparison with GRID/GOLPE methods. 2000
  - {{pubmed>long:10815771}}
  - Kiyoshi Hasegawa, Toshiro Kimura, Kimito Funatsu: GA Strategy for Variable Selection in QSAR Studies: Enhancement of Comparative Molecular Binding Energy Analysis by GA-Based PLS Method. Quantitative Structure-Activity Relationships, 18 (3) 262–272, July 1999.
  - Rebecca C. Wade, A. R. Oritz, F. Gago: Comparative binding energy analysis. Perspectives in Drug Discovery and Design, Volumes 9-11, January 1998 , 19-34(16).
  - {{pubmed>long:9526559}}
  - {{pubmed>long:9704299}}
  - {{pubmed>long:9089335}}
  - {{pubmed>long:7629807}}